INTRODUCTION {#SEC1}
============

Eukaryotic Argonaute proteins (eAgos) are the key players in RNA interference (RNAi) pathways (reviewed in ([@B1]--[@B3])). During RNAi, eAgos are loaded with small 5′-phosphorylated RNAs, ranging from 20 to 30 nt, in a pathway-specific ribonuclease-dependent process. The eAgos sometimes form the core of a multiprotein RNA-induced silencing complex (RISC; reviewed in ([@B4])). Depending on which proteins associate with eAgos, Argonaute-mediated target binding can be specifically adjusted to differentially control gene expression. RNA interference generally results in silenced expression of the target gene, via functional variations that include decreased transcription (heterochromatin formation), decreased translation (mRNA binding) and decreased mRNA half-life (mRNA cleavage, mRNA de-adenylation).

Whereas prokaryotes also possess Argonaute proteins (pAgos), they appear to lack the accessory proteins involved in eukaryotic RNA interference pathways ([@B3],[@B5],[@B6]). Initially, pAgo variants from *Aquifex aeolicus* and *Thermus thermophilus* were characterized biochemically, revealing that they could use DNA guides for RNA and DNA target cleavage ([@B7]--[@B9]). Recently, it has become evident that at least some bacterial Agos play a role in host defense by interfering with invading nucleic acids ([@B10]--[@B12]). *Rhodobacter sphaeroides* Argonaute (*Rs*Ago) acquires small RNA guides that allow interference with plasmid DNA ([@B10]). *T. thermophilus* Argonaute (*Tt*Ago) acquires 5′-phosphorylated single stranded DNA (ssDNA) guides termed small interfering DNAs (siDNAs). These siDNAs are utilized by *Tt*Ago to cleave ssDNA and double stranded DNA (dsDNA) targets, the latter by cleaving each of the strands individually ([@B11]).

Archaeal pAgos initially have been explored to get insights in structural organization of Argonaute proteins ([@B13],[@B14]). Along with the structure of *Archaeoglobus fulgidus* Argonaute (*Af*Ago), which is a truncated pAgo, the binding affinity of *Af*Ago for various nucleic acids has been described ([@B14]). The apo-*Af*Ago has a higher affinity for ssDNA and dsDNA molecules than for ssRNA and dsRNA molecules ([@B14]). The enzyme of *Methanocaldococcus jannaschii* (*Mj*Ago) is the only archaeal Argonaute of which *in vitro* activity assays have been reported, revealing that this protein can utilize DNA guides to cleave DNA targets ([@B15]). Like *Af*Ago, *Mj*Ago binds ssDNA and dsDNA molecules with a much higher affinity than ssRNA and dsRNA molecules ([@B15]). Furthermore, *Mj*Ago is unable to cleave RNA target strands. The physiological role of *Mj*Ago has not been characterized. *Mj*Ago belongs to a clade of euryarchaeal thermophilic Argonautes, which is the pAgo clade that is most closely related to the eukaryotic Argonautes ([@B3],[@B6]) (Figure [1A](#F1){ref-type="fig"}). This clade also contains the *Pyrococcus furiosus* Argonaute (*Pf*Ago). *P. furiosus* is a hyperthermophilic archaeon, like *A. fulgidus* and *M. jannaschii*, and grows optimally at temperatures between 80 and 100°C ([@B16]). *Pf*Ago was the first Ago whose complete three-dimensional structure was determined ([@B13]). However, the physiological role and the molecular mechanism of *Pf*Ago have not yet been reported. Despites belonging to the same clade, *Pf*Ago has only 28% shared identity with *Mj*Ago (BLASTp), which makes it difficult to predict the functionality of *Pf*Ago based on sequence homology alone. Furthermore, the closest related pAgo of which the function is determined is bacterial *Tt*Ago, that has a query cover of only 38%, and only 24% shared identities with *Pf*Ago (BLASTp). In the present study, a combination of *in vivo* and *in vitro* analyses demonstrates that archaeal *Pf*Ago is involved in host defense by mediating DNA-guided DNA interference.

![*Pf*Ago interferes with plasmid transformation. (**A**) Schematic phylogenetic tree of Argonaute proteins, adapted from ([@B3]). *Af*Ago: *Archaeoglobus fulgidus* Ago. *Rs*Ago: *Rhodobacter sphaeroides* Ago. *Tt*Ago: *Thermus thermophilus* Ago. *Aa*Ago: *Aquifex aeolicus* Ago. *Pf*Ago: *Pyrococcus furiosus* Ago. *Mj*Ago: *Methanocaldococcus jannaschii* Ago. eAgos: eukaryotic Agos. (**B**) Overview of *ago* gene loci of *P. furiosus* strains Pfu (wild-type), PfuΔ*ago* (knockout) and Pfu-*ago*-O/E (*Pf*Ago overexpression strain). (**C**) Immunoblot analysis of *Pf*Ago (indicated with a black triangle) content in Pfu and PfuΔ*ago* with Csa2 protein (indicated with a gray triangle) serving as the internal standard (left panel) or Pfu and Pfu-*ago*-O/E (right panel). The amount of lysate analyzed is indicated and the asterisk (\*) denotes apparent breakdown products observed when *Pf*Ago is overexpressed. (**D**) Plasmid transformation efficiencies of the *P. furiosus* strains. Error bars indicate standard deviations of biological triplicates.](gkv415fig1){#F1}

MATERIALS AND METHODS {#SEC2}
=====================

Strains and cultivation {#SEC2-1}
-----------------------

For *in vivo* experiments, *P. furiosus* strain JFW02 ([@B17]) was used, which is referred to in this chapter as Pfu or wild-type. Furthermore two genomic variants of strain JFW02, PfuΔ*ago* (*ago* knockout strain) and Pfu-*ago*-O/E (*ago* overexpression strain) were used (Figure [1](#F1){ref-type="fig"}; Supplementary Table S1). Strains were cultivated anaerobically in a defined medium with cellobiose as the carbon source ([@B18]) at 90°C in anaerobic culture bottles or on medium solidified with 1% (w/v) Gelrite (Research product international). For growth of uracil auxotrophic strains, the defined medium was supplemented with uracil to a final concentration of 20 μM.

Genomic mutants {#SEC2-2}
---------------

Pfu-*ago*-O/E was generated by transforming an NruI-linearized pHSG298 *ago* plasmid (Supplementary Table S2) into the wild-type Pfu strain. The plasmid contains the gene encoding *Pf*Ago with an upstream *Thermococcus kodakaraensis* csg promoter, flanked by PF1223 and PF1224 gene sequences for homologous recombination. Furthermore, the plasmid encodes TrpA and TrpB with an upstream gdh promoter. The plasmid was constructed by overlap polymerase chain reaction and oligonucleotides used to generate this plasmid are shown in Supplementary Table S3. Two rounds of colony purification was performed by plating 10^−3^ dilutions of transformant cultures onto selective plate medium (without tryptophan) and picking isolated colonies into selective liquid medium. The PfuΔ*ago* was created by pop-out marker replacement strategy as described previously ([@B17]). The sequences of oligonucleotide used are shown in Supplementary Table S3.

Transformation experiments {#SEC2-3}
--------------------------

Plasmid transformation was performed as described previously using 2.5 ng plasmid DNA μl^−1^ of culture ([@B18]). pJFW18 plasmid ([@B19]) and a modified pYS3 plasmid ([@B20]) were used (Supplementary Table S2). The modified pYS3 plasmid was generated by replacement of the Sim^R^ cassette of pYS3 by the Pgdh pyrF cassette from pJFW18. The sequences of oligonucleotides used are shown in Supplementary Table S3. The transformation efficiencies reported were calculated as the number of transformed colonies per μg of DNA added.

*Pf*Ago antibodies and *Pf*Ago immunodetection {#SEC2-4}
----------------------------------------------

Polyclonal antibodies were raised in chickens against purified (nickel chromatography) N-terminal, 6X His-tagged recombinant *Pf*Ago or *Pf*Csa2 (loading control) proteins as previously described ([@B21]). Western blotting was performed by standard procedures. The blots were incubated with polyclonal IgY immune antibodies and HRP-conjugated Anti-IgY secondary antibody (Gallus Immunotech). The protein bands on the blots were detected using an enhanced chemiluminescent substrate for HRP (horse radish peroxidase) activity (GE Life Sciences) and exposure to autoradiography film.

Sequence and structural alignments {#SEC2-5}
----------------------------------

For the active site residue sequence alignment, previously published alignments were used ([@B3]). For structural alignments, structures from *Pf*Ago (PDB: 1Z25) and *Tt*Ago (PDB: 4N47) were loaded in PyMOL. All residues but the MID and PIWI domains were deleted and the remaining residues were aligned with the PyMOL software. For clarity, only residues forming the active site of *Pf*Ago, and active site residues of *Tt*Ago were displayed.

*Pf*Ago expression and purification {#SEC2-6}
-----------------------------------

A synthetic codon-optimized gene encoding *Pf*Ago with an N-terminal Strep(II)-tag was ordered from GenScript USA Inc. and was directionally cloned into expression vector pCDF-1b as indicated in Supplementary Table S2 (pWUR790). Plasmids pWUR791-pWUR796 (Supplementary Table S2) were generated by introducing mutations according to an adapted QuikChange Site-Directed mutagenesis Kit instruction manual (Stratagene) using primers described in Supplementary Table S3. These plasmids were transformed into *Escherichia coli* KRX (Promega) according to the protocol provided by the manufacturer. Strains were cultivated in LB medium containing 50 μg ml^−1^ streptomycin and 0.4% (w/v) glucose in a shaker incubator at 37°C. After overnight incubation, cultures were centrifuged for 5 min at 4700 × *g*, after which the supernatant was removed. Cell pellets were resuspended in LB medium containing 50 μg ml^−1^ streptomycin and incubated in shaker incubator at 37°C until an OD~600\ nm~ of 0.6--0.8 was reached. Cultures were cold-shocked by incubation in an ice bath for 15 min. *Pf*Ago expression was induced by adding isopropyl-b-D-thiogalactoside (IPTG) and L-Rhamnose to a final concentration of 1 mM and 0.1% (w/v), respectively. Expression was continued in a shaker incubator at 20 or 37°C for 16 h. Cells were collected by centrifugation for 15 min at 6000 × *g*, after which the supernatant was removed. Cells were resuspended in Buffer I (20 mM Tris/HCl pH 8, 1 M NaCl, 2 mM MnCl~2~) and disrupted by sonication with a Branson Sonifier B-12 and Branson Converter with a 5 mm tip (ten 30 s pulses at 30% power with 30 s pause between pulses). The solution was centrifuged for 30 min at 32 913 × *g* at 4°C, after which the supernatant was used for purification by Strep-Tactin affinity chromatography (IBA, Germany) with an adapted protocol. Before loading of the supernatant, the Strep-Tactin Sepharose column was equilibrated with Buffer I. After loading, the column was washed 16 CV (column volumes) Buffer I. N-terminally Strep(II)-tagged *Pf*Ago was eluted in Buffer II (buffer I supplemented with 2.5 mM biotin (Sigma-Aldrich)). For purification of *Pf*Ago used in cation preference and cation gradient experiments, no MnCl~2~ was added to the purification buffers.

Activity assays {#SEC2-7}
---------------

For activity assays, elution fractions containing *Pf*Ago or *Pf*Ago mutants were diluted with Buffer II to a final protein concentration of 5 μM. A total of 5 μl protein sample was mixed with synthetic ssDNA or ssRNA guides (Supplementary Table S3) in a 5:1 ratio (protein:guide) in reaction buffer (20 mM Tris/HCl, pH 8) and incubated for 15 min at 95°C. After pre-incubation, ssDNA or ssRNA targets (Supplementary Table S3) were added to a final 5:1:1 ratio (protein:guide:target) and incubated for 1 h at 95°C. Final reaction concentrations were 15 mM Tris/HCl pH 8, 250 mM NaCl, 0.5 μM MnCl~2~, 1.25 μM protein, 0.25 μM guide and 0.25 μM target. Note that in different experiments incubation temperature, incubation time and salt concentration were varied (indicated in figures of corresponding experiments). For cation preference experiments, *Pf*Ago or *Pf*AgoDM and ssDNA guides (Supplementary Table S3) were mixed in a 5:1 ratio (protein:guide) in reaction buffer to which different cations were added, and incubated for 15 min at 95°C. After pre-incubation, ssDNA targets (Supplementary Table S3) were added to a final 5:1:1 ratio (protein:guide:target) and incubated for 1 h at 95°C. Final reaction concentrations were 15 mM Tris/HCl pH 8, 250 mM NaCl, 0.5 mM metal-Cl~2~ (FeCl~2~, CoCl~2~, CuCl~2~, NiCl~2~, MgCl~2~, MnCl~2~, ZnCl~2~ or CaCl~2~), 1.25 μM protein, 0.25 μM guide, 0.25 μM target). After incubation Loading Buffer (95% (deionized) formamide, 5 mM ethylenediaminetetraacetic acid, 0.025% sodium dodecyl sulphate, 0.025% Bromophenol blue and 0.025% xylene cyanol) was added in a 1:1 ratio and samples were incubated for 10 min at 95°C before resolving on 15 or 20% denaturing polyacrylamide gels. Nucleic acids were stained using SYBR gold Nucleic Acid Gel Stain (Invitrogen) and visualized using a G:BOX Chemi imager (Syngene). For plasmid assays, elution fractions containing *Pf*Ago or *Pf*Ago mutants were diluted with Buffer II to a final protein concentration of 5 μM. A total of 5-μl protein sample was mixed with synthetic ssDNA guides (Supplementary Table S3) in a 5:1 ratio (protein:guide) in reaction buffer (20 mM Tris/HCl, pH 8 and varying NaCl concentrations) and incubated for 15 min at 95°C. After pre-incubation, ∼200--300 ng plasmid pWUR704 or pWUR790 (Supplementary Table S2) was added, and the samples (final reaction concentrations were 15 mM Tris/HCl pH 8, 0.5 μM MnCl~2~, and 250 mM or 500 mM NaCl) were incubated for 16 h at 75°C. Reactions were stopped by adding Proteinase K solution (Ambion) and CaCl~2~ (final concentration 5 mM) and samples were incubated for 1 h at 65°C. Samples were mixed with 6× loading dye (Thermo Scientific) before they were resolved on 0.8% agarose gels. As marker, either a 1 kb Generuler Marker (Thermo Scientific) or 1 kb DNA ladder (New England Biolabs) and additionally a custom plasmid marker, were used. The custom plasmid marker consisted of non-treated pWUR704 (mostly in supercoiled conformation), Nb.BSMI (New England Biolabs) nicked pWUR704 (open circular conformation) and BcuI (Thermo Scientific) linearized pWUR704. Agarose gels were stained with SYBR-gold Nucleic Acid Gel Stain (Invitrogen) and visualized using a G:BOX Chemi imager (Syngene).

Guide co-purification {#SEC2-8}
---------------------

About 1/10 volume Proteinase K (Ambion) and 1/10 volume CaCl~2~ (50 mM) were added to 500 pmol purified proteins in Buffer II and samples were incubated for 4 h at 65°C. Nucleic acids were separated from protein content using Roti(R) Phenol/Chloroform/Isoamyl alcohol (Carl Roth GmbH). About 1/10 volume 3 M NaAc (pH 5.2) and 10 μl 0.5% linear polyacrylamide was added, before addition of 96% ethanol in a 2:1 ratio (v/v, ethanol:sample). Samples were incubated at −20°C for 2 days and centrifuged for 30 min at 4°C at 20 000 × rpm in a table top centrifuge. Supernatant was removed and the pellet was dried for 10 min at 50°C. The pellet was washed in 70% ethanol, followed by centrifugation for 30 min at 4°C at 20 000 × rpm in a table top centrifuge. Supernatant was removed and the pellet was dried for 10 min at 50°C. The pellet was resuspended in 50 μl MilliQ H~2~O. Purified nucleic acids were \[γ-^32^P\] ATP labeled with T4 PNK (Thermo Scientific) in exchange or forward labeling reactions, in which 5′ phosphates or 5′ OH groups are labeled, respectively. Nucleic acids were separated from free \[γ-^32^P\] ATP using a Sephadex G-25 column (GE). Nucleic acids were incubated with DNase-free RNase A (Thermo Scientific) or RQ1 RNase-free DNase I (Promega) for 1 h at 37°C. Samples were mixed with Loading Buffer in a 1:1 ratio and samples were incubated for 10 min at 95°C. \[γ-^32^P\] ATP labeled nucleic acids were resolved on 20% denaturing polyacrylamide gels. Radioactivity was captured from gels using phosphor screens.

RESULTS {#SEC3}
=======

*Pf*Ago interferes with plasmid DNA transformation {#SEC3-1}
--------------------------------------------------

To elucidate the physiological role of *Pf*Ago in *P. furiosus* JFW02 (Pfu) ([@B17]), an *ago* knockout strain (PfuΔ*ago*) and an *ago* overexpressing strain (Pfu-*ago*-O/E) were generated (Figure [1B](#F1){ref-type="fig"}). Immunoblots demonstrate that *Pf*Ago is expressed in Pfu, while no *Pf*Ago is detected in PfuΔ*ago* (Figure [1C](#F1){ref-type="fig"}). Approximately 200-fold increased levels of full-length *Pf*Ago were detected in the Pfu-*ago*-O/E strain (Figure [1C](#F1){ref-type="fig"}). Bacterial *Tt*Ago has previously been described to be involved in host defense by interfering with plasmid transformation ([@B11],[@B12]). In the latter studies, transformations were performed using the natural competence system of *T. thermophilus*, which transports extracellular DNA into the cell ([@B22]). *P. furiosus* JFW02 also has a natural competence system ([@B18]). This allowed comparing natural transformation efficiencies of strains Pfu, PfuΔ*ago* and Pfu-*ago-*O/E. Each strain was transformed with plasmid pJFW18 ([@B19]) or with plasmid pYS3 ([@B20]). For both plasmids, transformation efficiency is ∼1.5 to 2.5-fold higher in PfuΔ*ago* compared to wild-type Pfu (Figure [1D](#F1){ref-type="fig"}, *P* \< 0.001). When *Pf*Ago is overexpressed, the transformation efficiency is lowered even further (Figure [1D](#F1){ref-type="fig"}, *P \<* 0.001). This demonstrates that archaeal *Pf*Ago lowers competence by interfering with plasmid transformation.

*Pf*Ago has a DEDH catalytic tetrad {#SEC3-2}
-----------------------------------

Target cleavage by Agos is mediated by a conserved DEDX triad, of which the X can be a histidine or an aspartic acid ([@B3]) (Figure [2A](#F2){ref-type="fig"}). Whereas the DDX residues are positioned close together in the available pAgo structures, the glutamic acid (E) is located on a structural sub-domain termed the 'glutamate finger' ([@B23]). In *Tt*Ago, this finger is located at a distance of 12.8 Å from the catalytic site when no target nucleic acid is bound (unplugged conformation), but it is inserted into the catalytic site (plugged-in conformation) upon target binding ([@B24]). To identify the catalytic residues of *Pf*Ago, a sequence alignment ([@B3]) and a structural alignment of *Tt*Ago and *Pf*Ago were analyzed (Figure [2A](#F2){ref-type="fig"}, [B](#F2){ref-type="fig"}). Previously, it was predicted that the catalytic site of *Pf*Ago includes residues D558, D628 and E635 ([@B13]). However, E635 is located away from the catalytic site residues of other Agos both in sequence and structural alignments (Figure [2](#F2){ref-type="fig"}). In contrast, H745 perfectly aligns with catalytic residues from other Agos in both sequences and structures. Like in the structure of unplugged *Tt*Ago, the glutamate finger of *Pf*Ago is unplugged in the structure of *Pf*Ago (Figure [2B](#F2){ref-type="fig"}). However, the *Pf*Ago glutamate finger encompasses two glutamic acids (E592 and E596). Which of these two glutamate residues is involved in target cleavage is impossible to deduce from the sequence alignment or from the available *Pf*Ago structure (unplugged conformation).

![DEDH catalytic site of *Pf*Ago. (**A**) Sequence alignment of human AGO2 (hAGO2), *Tt*Ago, *Mj*Ago and *Pf*Ago, adapted from ([@B3]). Only regions containing the DEDX catalytic residues (indicated in red) are shown. *Pf*Ago catalytic residues E592 and E596 are colored orange. (**B**) *Tt*Ago catalytic residues DEDD (yellow; PDB: 4N47) aligned to *Pf*Ago catalytic site (black; PDB: 1Z25). Predicted catalytic residues of *Pf*Ago are colored green. (**C**) Synthetic 21 nucleotide siDNA (red) and 98 nucleotide ssDNA target (blue) used for *in vitro* activity assays. The black triangle indicates the predicted cleavage site, black lines indicate the predicted 59 and 39 nucleotide cleavage products. (**D**) *Pf*Ago and mutants were loaded with a 21 nucleotide long siDNA and were incubated with a 98 nucleotide ssDNA target in a 5:1:1 molar ratio (*Pf*Ago:guide:target). Products were resolved on a 15% denaturing polyacrylamide gel. M: ssDNA marker. nt: nucleotide. The 'Control' sample contains no protein.](gkv415fig2){#F2}

To experimentally identify the residues involved in *Pf*Ago activity, Strep(II)-tagged *Pf*Ago and five predicted catalytic mutants were heterologously produced in *E. coli* KRX. After affinity purification, expressed *Pf*Ago variants were tested for activity. As both *Tt*Ago and *Mj*Ago (which is closely related to *Pf*Ago) can utilize DNA guides to cleave ssDNA targets, we incubated *Pf*Ago with synthetic 5′-phosphorylated, 21 nt long siDNAs. Subsequently, a synthetic 98 nt ssDNA target was added (Figure [2C](#F2){ref-type="fig"} and [D](#F2){ref-type="fig"}). After 1 h incubation at 95°C with *Pf*Ago and with *Pf*Ago^E592A^, all ssDNA target is cleaved (Figure [2D](#F2){ref-type="fig"}). This indicates that *Pf*Ago can utilize siDNAs to cleave DNA targets. In contrast, *Pf*Ago mutants D558A, E596A, D628A and H745A show impaired activity (Figure [2D](#F2){ref-type="fig"}), indicating that the latter residues form the DEDH catalytic tetrad of *Pf*Ago.

Requirements for target cleavage by *Pf*Ago {#SEC3-3}
-------------------------------------------

To further determine the prerequisites for *Pf*Ago-mediated target cleavage, we tested the influence of temperature, salt concentration and divalent cation type on siDNA-guided ssDNA cleavage. As a negative control, we used a catalytic double mutant, *Pf*AgoDM (*Pf*Ago^D558A,D628A^). For all assays, the guide and target shown in Figure [2C](#F2){ref-type="fig"} were used. *Pf*Ago is most active in the range from 87 °C to 99.9 °C (Figure [3A](#F3){ref-type="fig"}; higher temperatures were not tested). Longer (16 h) incubations show that *Pf*Ago exhibits some activity at 37°C, but not at 20°C (Figure [3B](#F3){ref-type="fig"}). *Pf*Ago is active in reactions with a NaCl concentration of 50 to 250 mM, whereas at NaCl concentrations of 500 to 1000 mM the activity is lowered or absent (Figure [3C](#F3){ref-type="fig"}; Supplementary Figure S1). To investigate if *Pf*Ago functions as a multi-turnover protein *Pf*Ago, siDNAs and ssDNA targets were incubated in a 2.5:1:20 ratio (*Pf*Ago:siDNA:target). *Pf*Ago--siDNA complexes cleave \>95% of the 20-fold excess of target DNA within 30 min in buffer with 250 mM NaCl (Supplementary Figure S1). To investigate if higher NaCl concentrations inhibit multi-turnover reactions (for example by restricting the release of cleaved target strands) we additionally performed the same experiment at 500 mM and 1 M NaCl (Supplementary Figure S1). Even after 16 h, no activity is observed at 1M NaCl. At 500 mM NaCl the activity of *Pf*Ago is severely lowered, but it still depletes the 20-fold excess of target DNA after 16 h, indicating that high NaCl concentrations do not inhibit the multi-turnover characteristic of *Pf*Ago.

![Effect of temperature, salt concentration and cation on *Pf*Ago activity. *Pf*Ago loaded with a 21 nt long siDNA was incubated with a 98 nt ssDNA target (see Figure [2C](#F2){ref-type="fig"}) in a 5:1:1 molar ratio (*Pf*Ago:guide:target) under various conditions. Unless otherwise indicated, target cleavage took place at 95°C for 1 h, with 0.5 mM Mn^2+^ as cation. Nucleic acids are resolved on denaturing polyacrylamide gels. M: ssDNA marker. nt: nucleotide. (**A**) *Pf*Ago activity is highest at temperatures between 90 and 99.9°C. (**B**) *Pf*Ago shows activity at temperatures ≥37°C if incubation is extended. (**C**) NaCl concentrations ≥500 mM interfere with *Pf*Ago activity. (**D**) *Pf*Ago-guide complexes show Co^2+^ and Mn^2+^ mediated ssDNA target cleavage. (**E**) Mn^2+^ is preferred above Co^2+^ as cation for *Pf*Ago-guide mediated ssDNA target cleavage.](gkv415fig3){#F3}

Next, we investigated which divalent cations *Pf*Ago can utilize to mediate siDNA-guided DNA target cleavage. *Pf*Ago is able to utilize Mn^2+^ and Co^2+^ as cation, with Mn^2+^ being a better cation than Co^2+^ (Figure [3D](#F3){ref-type="fig"} and [E](#F3){ref-type="fig"}). In contrast to the phylogenetically closely related *Mj*Ago ([@B15]), *Tt*Ago ([@B9],[@B11],[@B24]) and eAgos ([@B25]), *Pf*Ago is unable to use Mg^2+^ as cation for its activity (Figure [3D](#F3){ref-type="fig"}). Also Fe^2+^, Cu^2+^, Ni^2+^ and Ca^2+^ do not allow siDNA-guided *Pf*Ago cleavage of ssDNA (Figure [3D](#F3){ref-type="fig"}). As eAgos have been shown to preferentially bind guides with specific 5′-end nucleotides ([@B26],[@B27]), we tested if *Pf*Ago has a preference for a specific 5′-end nucleotide on the siDNA. Like *Tt*Ago, *Pf*Ago is able to utilize siDNAs with different 5′-end nucleotides equally well (Supplementary Figure S2).

*Pf*Ago is a DNA-guided protein that cleaves DNA targets {#SEC3-4}
--------------------------------------------------------

To investigate whether *Pf*Ago acquires specific guides *in vivo*, we analyzed nucleic acids that co-purify with *Pf*Ago after expression in *E. coli*. No DNA was observed in RNase A-treated samples, whereas in DNase I-treated samples it was observed that RNAs of undefined length co-purify with *Pf*Ago and *Pf*AgoDM (Supplementary Figure S3). The latter is suspected to be non-specifically bound RNA, as has previously been described for purification of *Tt*Ago and *Tt*AgoDM ([@B3]). This is supported by the observation that RNAs associate with *Pf*Ago purified in presence and absence Mn^2+^, whereas a divalent cation is required for specific binding of the 5′ end of the guide by pAgos ([@B28]). Unfortunately, attempts to identify guides associated with *Pf*Ago expressed in *P. furiosus* were not successful (data not shown).

To investigate if besides ssDNA, ssRNA can also guide *Pf*Ago activity, *Pf*Ago was incubated with 21 nt DNA or RNA guides after which 45 nt ssDNA or ssRNA targets were added (Figure [4A](#F4){ref-type="fig"} and [B](#F4){ref-type="fig"}). As expected, *Pf*Ago catalyzes siDNA-guided cleavage of complementary DNA targets (Figure [4B](#F4){ref-type="fig"}). In contrast to *Tt*Ago, *Pf*Ago does not show siDNA-guided cleavage of RNA targets (Figure [4B](#F4){ref-type="fig"}). With the RNA guide, we did not observe any *Pf*Ago-mediated cleavage, neither of ssDNA nor of ssRNA targets. This implies that *Pf*Ago only mediates DNA-guided DNA interference. In addition, the DNA guide length range of *Pf*Ago was tested. *Pf*Ago-mediated cleavage of DNA targets is only observed with siDNAs with a length ranging from 15 to at least 31 nt (longer not tested; Figure [4C](#F4){ref-type="fig"} and [D](#F4){ref-type="fig"}). *Tt*Ago utilizes siDNAs with a length ranging from 9 to at least 36 nt (longer not tested) ([@B29]). As guides with a length of 31 nt are too long for canonical guide binding by Ago, it has been hypothesized that the guide adopts an alternative trajectory to allow 3′ end insertion into the PAZ binding pocket ([@B29]). Alternatively, the 3′ end of guide sticks out of the protein, as the nucleic acid-binding channel of *Tt*Ago is open to the outside ([@B29]). Most likely, the same is true for *Pf*Ago.

![*Pf*Ago utilizes 15--31 nt long siDNAs for ssDNA target cleavage. *Pf*Ago was incubated with various guides and targets in a 5:1:1 ratio (*Pf*Ago:guide:target). Unless otherwise indicated, target cleavage took place at 75°C for 1 h, with 0.5 mM Mn^2+^ as cation. Nucleic acids are resolved on denaturing polyacrylamide gels. M: ssDNA marker. (**A**) Synthetic DNA and RNA guides (black) and targets (gray). The black triangle indicates the predicted cleavage site, black lines indicate the predicted 11 and 34 nt cleavage products. (**B**) *Pf*Ago shows only DNA-guided DNA cleavage. (**C** and **D**) Both at 95 and 75°C, *Pf*Ago-mediated target cleavage is facilitated by siDNAs which are at least 15 nt long. C: control reaction with *Pf*AgoDM and 21 nt long siDNA.](gkv415fig4){#F4}

*Pf*Ago mediates guide-free and siDNA-guided cleavage of dsDNA plasmids {#SEC3-5}
-----------------------------------------------------------------------

To test whether *Pf*Ago cleaves plasmid DNA, *Pf*Ago was incubated with its expression plasmid pWUR790 (Figure [5A](#F5){ref-type="fig"}). As incubation of this plasmid at 95°C in the presence of Mn^2+^ results in degradation of the plasmid (even in the absence of *Pf*Ago), we incubated the reaction mixtures at 75°C for 16 h. Still, the majority of the plasmid DNA is turned to the open circular confirmation under these conditions, even in absence of *Pf*Ago (Figure [5B](#F5){ref-type="fig"}). Strikingly, pWUR790 is linearized when incubated with *Pf*Ago in absence of guides (Figure [5B](#F5){ref-type="fig"}). We observed this suspected guide-free *Pf*Ago-mediated cleavage of pWUR790 in buffer with 250 mM NaCl, but not in buffer with 500 mM NaCl (Figure [5B](#F5){ref-type="fig"}). These findings suggest either that *Pf*Ago cleaves plasmids independently of co-purified DNAs or that DNA guides are utilized but the concentration of such co-purified DNA is below the detection limit of the assay. It has previously been demonstrated that *in vivo, Tt*Ago acquires guides that allow for targeting its expression vector ([@B11]). To rule out that this *Pf*Ago activity was guided by co-purified RNA or by co-purified DNA guides that we were unable to detect, we used pWUR704 as target plasmid (Figure [5C](#F5){ref-type="fig"}). pWUR704 has minimal sequence similarity to the *Pf*Ago expression vector (pWUR790; no sequences longer than 13 consecutive identical base pairs between the two plasmids). After incubation without *Pf*Ago, the plasmid is present both in open circular and supercoiled configuration (Figure [5E](#F5){ref-type="fig"}, lane 1). When *Pf*Ago is added, supercoiled pWUR704 is linearized even in absence of guides (Figure [5E](#F5){ref-type="fig"}, lane 2). Like pWUR790 cleavage, this activity is more pronounced at 250 mM NaCl compared to 500 mM NaCl. In contrast, *Tt*Ago, which co-purified with detectable levels of siDNA, was unable to cleave pWUR704, unless synthetic siDNAs targeting pWUR790 were added ([@B3]). Low levels of guide-free *Pf*Ago-mediated nicking of pWUR704 takes place within 1 h incubation at 75°C (Supplementary Figure S4). As *Pf*Ago does not mediate RNA-guided activity within the same time span (Figure [4](#F4){ref-type="fig"}), it is unlikely that the activity on plasmid DNA is mediated by RNA that co-purified with *Pf*Ago. Instead, these findings suggest that *Pf*Ago has the potential to cleave the plasmid independently of guides.

![Plasmid cleavage by *Pf*Ago. (**A**) pWUR790 expression plasmid. (**B**) *Pf*Ago expressed at 20°C and purified in absence of Mn^2+^ cleaves expression plasmid pWUR790. Agarose gels with plasmid targets incubated without protein (lane 1), with *Pf*AgoDM (lane 2) and with *Pf*Ago (lane 3). M1: 1-kb DNA ladder (New England Biolabs). M2: pWUR790 marker with open circular (OC), linearized (LIN) and supercoiled (SC) pWUR790. (**C**) pWUR704 target plasmid, target site indicated in gray. (**D**) Target region (gray) and FW and RV siDNA guides (black). Predicted cleavage sites are indicated with a black triangle. (**E**) Agarose gels with plasmid targets incubated with *Pf*AgoDM (lane 1), with guide free *Pf*Ago (lane 2) and with *Pf*Ago loaded with FW siDNA, RV siDNA, or both (lane 3--5) in reaction buffer with 250 mM NaCl (left panel) or 500 mM NaCl (right panel). M1: 1 kb GeneRuler marker (Thermo Scientific). M2: pWUR704 marker with open circular (OC), linearized (LIN) and supercoiled (SC) pWUR704.](gkv415fig5){#F5}

We next investigated whether siDNAs can guide *Pf*Ago-mediated plasmid cleavage. We loaded *Pf*Ago either with a FW siDNA targeting the (−) strand of pWUR704 or with a RV siDNA targeting the (+) strand of pWUR704 (Figure [5D](#F5){ref-type="fig"}). *Pf*Ago and *Pf*Ago--siDNA complexes were incubated with plasmid pWUR704 as target, in buffers containing 250 or 500 mM NaCl. Additionally, both *Pf*Agos complexes with FW guides and with RV guides were mixed and incubated with pWUR704. *Pf*Ago loaded with a single siDNA nicks the plasmid DNA, generating open circular plasmids (Figure [5E](#F5){ref-type="fig"}, lane 3 and 4). Interestingly, reactions to which FW or RV siDNAs are added contain more open circular plasmid compared to the sample to which no siDNA is added, in which plasmids are mostly turned to the linear state. This suggests siDNA loading hinders guide-free *Pf*Ago activity or alternatively that guide-free cleavage of plasmid DNA by *Pf*Ago requires plasmid supercoiling. Incubation of the plasmids with *Pf*Ago--siDNA complexes targeting both strands of the plasmid results in plasmid linearization (Figure [5E](#F5){ref-type="fig"}, lane 5). Both processes are performed more efficiently in reactions with 250 mM NaCl as compared to reactions with 500 mM NaCl. More efficient cleavage at 250 mM NaCl has also been observed for ssDNA targets (Figure [3C](#F3){ref-type="fig"}). These findings demonstrate that *Pf*Ago--siDNA complexes can target dsDNA plasmids, resulting in a dsDNA breaks if both strands of the plasmid DNA are targeted.

DISCUSSION {#SEC4}
==========

This work describes the first combined *in vivo* and *in vitro* characterization of an archaeal Argonaute. *Pf*Ago functions as a DNA-guided DNA endonuclease that requires divalent cations such as Mn^2+^ or Co^2+^ for its activity. It utilizes 5′-phosphorylated ssDNA guides that are at least 15 and up to at least 31 nt long. As such long guides cannot be bound canonically, we predict that the 3′-end of the guide 'sticks out' a gap in the PAZ domain. Whether this gap exists in the PAZ domain of *Pf*Ago and the function of this predicted feature remain to be determined. Like the bacterial *Tt*Ago, archaeal *Pf*Agos can utilize a single siDNA to nick plasmid DNA, while two *Pf*Ago--siDNA complexes (each targeting a single strand of the plasmid) together can generate dsDNA breaks. Both pAgos mediate host defense by interfering with invading plasmid DNA (Figure [1](#F1){ref-type="fig"}). As *Tt*Ago and *Pf*Ago do not belong to the same branch in the phylogenetic tree, these findings suggest a broad conservation of pAgo functions. Nevertheless, *Pf*Ago has some interesting characteristics: *Pf*Ago cannot use Mg^2+^ as cation (while *Tt*Ago and *Mj*Ago can ([@B11],[@B15])) and *Pf*Ago--siDNA complexes do not mediate RNA target cleavage (while *Tt*Ago--siDNA complexes do ([@B9])). The preference for DNA or RNA guides or targets of eAgos, *Tt*Ago and *Pf*Ago most likely is determined on a structural level. The guide-target duplex binding channel and guide 5′-end binding pockets of eAgos are strongly positively charged, allowing RNA guide and target binding. In contrast, the duplex binding channels of *Tt*Ago and *Pf*Ago are much less positively charged and their guide 5′-end binding pockets are hydrophobic ([@B30]), possibly excluding the possibility to bind RNA guides. However, this hypothesis requires further investigation before any claims can be made.

We were unable to co-purify siDNA guides from *Pf*Ago heterologously expressed in *E. coli* KRX. Possibly *Pf*Ago is not able to acquire guides at the low temperatures at which it is expressed (20 or 37°C) or it requires host factors for guide generation and/or loading. Future research should focus on guides associated with *Pf*Ago expressed in *P. furiosus*. Interestingly, under some conditions, *Pf*Ago appears to cleave dsDNA plasmids in absence of siDNAs, suggesting that *Pf*Ago shows unguided, non-specific nuclease activity (Figure [5](#F5){ref-type="fig"}). We have observed similar activity for *Tt*Ago under specific conditions (Swarts *et al*., unpublished results) and hypothesize that unguided dsDNA cleavage might be related to the generation of siDNAs.

We chose to characterize *Pf*Ago as it belongs to the clade of euryarchaeal pAgos, which is the clade of pAgos that is most closely related to eAgos (Figure [1A](#F1){ref-type="fig"}). eAgos are best known for their RNA-guided RNA cleaving role in RNA interference. Therefore, we predicted that *Pf*Ago possibly was involved in both RNA interference and DNA interference. In contrast, *Pf*Ago solely mediates DNA cleavage in a DNA guide-dependent manner. Strikingly, a recent comment paper cites numerous papers in which DNA binding by eAgo has been described ([@B31]). It was suggested that some eAgos might be involved in DNA binding, a hypothesis that requires further investigation. As *Pf*Ago is one of the pAgos most closely related to eAgos, these findings suggest that eAgos were derived from the same ancestors as *Pf*Ago, which might have utilized DNA guides and/or DNA targets as well. Alternatively, the pAgos changed their guide and target specificity multiple times during evolution. Combined, these findings indicate that bacterial and archaeal Argonautes and possibly even ancient eukaryotic Argonautes, mediate host defense by DNA-guided DNA interference.
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[Supplementary Data](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkv415/-/DC1) are available at NAR Online.
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